Portal de investigación
ESTUDIO POSTAUTORIZACIONAL, MULTICÉNTRICO, OBSERVACIONAL, RETROSPECTIVO PARA EVALUAR LA EFICACIA, SEGURIDAD Y TOLERABILIDAD DE LACOSAMIDA COMO FÁRMACO ANTICONVULSIVANTE EN PACIENTES CON CRISIS SECUNDARIAS A TUMOR CEREBRAL.
Datos básicos
- Código:
- FPC-LAC-2013-01
- Protocolo:
- FPC-LAC-2013-01
- EUDRACT:
- NCT:
- Centro:
- Dotación:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
A phase I study of irinotecan in combination with metronomic temozolomide in patients with recurrent glioblastoma
Reynes, G; (...); Garcia, JL
Article. 10.1097/CAD.0000000000000059. 2014
A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
Sepulveda, JM; (...); Balana, C
Article. 10.1007/s12094-015-1304-0. 2015
BCAS1 defines a heterogeneous cell population in diffuse gliomas.
Morales-Gallel, Raquel; (...); Garcia-Verdugo, Jose Manuel
Article. 10.18632/oncotarget.28553. 2024
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial
Balana C; (...); Villà S
Article. 10.1007/s11060-016-2065-5. 2016
Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients
Balana, C; (...); Villa, S
Article. 10.1007/s12094-018-1883-7. 2018
Differential effect of vascularity between long- and short-term survivors with IDH1/2 wild-type glioblastoma.
Álvarez-Torres MDM; (...); Garcia-Gomez, Juan Miguel
Article. 10.1002/nbm.4462. 2021
Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study
Sepulveda-Sanchez, JM; (...); Belenguer, A
Article. 10.3892/ol.2017.5988. 2017
Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib
Cebrian, A; (...); Garcia-Foncillas, J
Article. 10.1038/srep41371. 2017
Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients
Molina D; (...); Pérez-García VM
Article. 10.1371/journal.pone.0161484. 2016
In silico validation of serum protein profile in long- and short-term glioblastoma survivors: A proteomic approach to prognostic factors
Bruixola, G.; (...); Reynes, G.
Meeting Abstract. 10.1016/S0959-8049(16)31646-X. 2015
Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification.
Álvarez-Torres MDM; (...); Garcia-Gomez, Juan Miguel
Article. 10.1186/s12885-021-09117-4. 2022
Multi-parametric MR Imaging Biomarkers Associated to Clinical Outcomes in Gliomas: A Systematic Review.
Oltra-Sastre M; (...); Garcia-Gomez JM
Article. 10.2174/1573405615666190109100503. 2019
Neuro-oncology information system: A comprehensive tool to improve quality of care
Salvador, C.; (...); Reynes, G.
Meeting Abstract. 10.1016/S0959-8049(16)31629-X. 2015
Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification
Sepulveda-Sanchez, JM; (...); Hernandez-Lain, A
Article. 10.1093/neuonc/nox105. 2017
Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma
Reynes, G; (...); Reche, E
Article. 10.1097/CAD.0000000000000314. 2016
Preliminarily results of the Oncohabitats Study: A multicentre validation of overall survival (OS) estimation of patients with glioblastoma (GBM) using vascular biomarkers
Alvarez-Torres, MD; (...); Garcia-Gomez, JM
Meeting Abstract. 10.1158/1538-7445.AM2019-4258. 2019
Radium-223 international early access program: results from the Spanish subset
Carles, J; (...); Castellano, D
Article. 10.2217/fon-2017-0297. 2018
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma
del Muro, XG; (...); Castellano, D
Review. 10.1007/s00280-014-2413-0. 2014
Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study.
Álvarez-Torres MDM; (...); García-Gómez JM
Article. 10.1002/jmri.26958. 2020
SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
Sepulveda-Sanchez, JM; (...); Gallego, O
Article. 10.1007/s12094-017-1790-3. 2018
SEOM clinical guideline of diagnosis and management of low-grade glioma (vol 20, pg 3, 2017)
Sepulveda-Sanchez, JM; (...); Gallego, O
Correction. 10.1007/s12094-017-1814-z. 2018
Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study
Balaña C; (...); Verger E
Article. 10.1007/s11523-014-0305-1. 2014
Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study.
Munárriz J; (...); Chirivella I
Article. 10.1007/s00280-019-03913-3. 2019
Upregulation of sFRP3 circulating expression levels correlates survival outcomes in glioblastoma
Bruixola, G; (...); Reynes, G
Meeting Abstract. 2019
VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.
Fleitas T; (...); Reynés G
Article. 10.1007/s12094-013-1020-6. 2013